Novartis (NYSE:NVS) reported fourth-quarter adjusted earnings that beat analyst estimates on Wednesday, but the Swiss pharmaceutical giant issued a cautious 2026 outlook as it prepares to navigate the largest wave of patent expirations in its history.
UBS Group (NYSE:UBS) reported a sharper-than-expected rise in fourth-quarter profit on Wednesday, signaling that the "last mile" of its historic integration of Credit Suisse is yielding significant cost efficiencies.
Novo Nordisk (NYSE:NVO) reported fourth-quarter results on Wednesday that exceeded analyst expectations, but shares plummeted as the Danish pharmaceutical giant issued a "shocking" outlook for 2026, warning of a potential double-digit decline in sales and profit.
Enterprise Products Partners (NYSE:EPD) reported fourth-quarter earnings that surpassed Wall Street expectations, as record volumes across its natural gas and liquids pipelines offset a slight year-over-year decline in full-year profitability.
Broadridge Financial Solutions (NYSE:BR) raised its full-year earnings forecast after reporting second-quarter results that swept past analyst estimates, driven by a surge in investor participation and steady growth in its recurring fee businesses.
Hamilton Lane (NASDAQ:HLNE) reached a historic milestone as its assets under management and supervision climbed to $1 trillion, coinciding with a fiscal third-quarter earnings report that handily surpassed Wall Street expectations.
Capri Holdings (NYSE:CPRI) today revealed third-quarter fiscal 2026 results, 2026, beating Wall Street expectations as the luxury group pivot's toward a leaner capital structure following the high-profile divestiture of Versace.
BellRing Brands (NYSE:BRBR) shares plunged 7.4% in early trading Tuesday after the nutrition giant’s first-quarter fiscal 2026 results revealed a sharp contraction in profit margins and a decelerating demand profile that overshadowed a top-line revenue beat.
Illinois Tool Works (NYSE:ITW) reported fourth-quarter earnings that surpassed analyst estimates and provided a bullish outlook for 2026, betting on its "Customer-Back Innovation" strategy to drive accelerated growth even as industrial markets remain mixed.
W.W. Grainger (NYSE:GWW) issued an optimistic outlook for 2026 after finishing a resilient fiscal 2025, during which the industrial distributor aggressively returned capital to shareholders despite a muted North American manufacturing environment.
Mesa Laboratories (NASDAQ:MLAB) reported a sharp increase in profitability for its third fiscal quarter, as strong demand for its biopharmaceutical tools more than offset a collapse in its Chinese diagnostic business.
Heartland Express (NASDAQ:HTLD) reported a net loss for the fourth quarter and full year of 2025, as the truckload carrier grappled with a persistent industry-wide freight recession and a significant non-cash impairment charge.
